Concentrix Corporation
CNXC
$37.35
-$0.91-2.38%
NASDAQ
| 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.15% | 3.40% | 11.31% | 21.66% | 35.20% |
| Total Other Revenue | -- | -74.88% | -44.40% | -5.65% | 41.39% |
| Total Revenue | 2.15% | 3.40% | 11.31% | 21.66% | 35.20% |
| Cost of Revenue | 3.58% | 4.85% | 12.14% | 22.12% | 36.00% |
| Gross Profit | -0.40% | 0.84% | 9.84% | 20.85% | 33.78% |
| SG&A Expenses | -0.63% | 15.86% | 23.13% | 32.24% | 53.96% |
| Depreciation & Amortization | -4.06% | -26.00% | 1.51% | 59.48% | 59.48% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.11% | 6.04% | 14.54% | 25.94% | 41.39% |
| Operating Income | 2.71% | -26.63% | -22.58% | -19.36% | -19.08% |
| Income Before Tax | -495.03% | 43.03% | -15.13% | -9.78% | -26.69% |
| Income Tax Expenses | 101.22% | 3.99% | -39.33% | -31.62% | -49.08% |
| Earnings from Continuing Operations | -609.09% | 54.16% | -8.05% | -3.13% | -19.95% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -609.09% | 54.16% | -8.05% | -3.13% | -19.95% |
| EBIT | 2.71% | -26.63% | -22.58% | -19.36% | -19.08% |
| EBITDA | -2.28% | -15.96% | -6.94% | 3.53% | 16.00% |
| EPS Basic | -656.83% | 53.45% | -15.82% | -17.75% | -35.72% |
| Normalized Basic EPS | 31.32% | -14.64% | -45.21% | -45.82% | -56.93% |
| EPS Diluted | -657.48% | 53.55% | -15.71% | -17.57% | -35.53% |
| Normalized Diluted EPS | 31.37% | -14.61% | -45.14% | -45.71% | -56.82% |
| Average Basic Shares Outstanding | -3.02% | -1.22% | 5.14% | 12.42% | 20.76% |
| Average Diluted Shares Outstanding | -3.07% | -1.28% | 5.03% | 12.22% | 20.46% |
| Dividend Per Share | 9.52% | 10.02% | 10.01% | 10.01% | 10.00% |
| Payout Ratio | -1.21% | -0.29% | 0.25% | 0.27% | 0.65% |